The insulin-like growth factor axis: A review of atherosclerosis and restenosis.
about
Neuraminidase-1, a subunit of the cell surface elastin receptor, desialylates and functionally inactivates adjacent receptors interacting with the mitogenic growth factors PDGF-BB and IGF-2The biological actions of dehydroepiandrosterone involves multiple receptorsRole of contractile prostaglandins and Rho-kinase in growth factor-induced airway smooth muscle contraction.An IGF-I promoter polymorphism modifies the relationships between birth weight and risk factors for cardiovascular disease and diabetes at age 36.IGF-1, oxidative stress and atheroprotectionInsulin receptor substrate-1/SHP-2 interaction, a phenotype-dependent switching machinery of insulin-like growth factor-I signaling in vascular smooth muscle cellsInsulin-like growth factor-I induces reactive oxygen species production and cell migration through Nox4 and Rac1 in vascular smooth muscle cellsDifferential regulation of vascular smooth muscle and endothelial cell proliferation in vitro and in vivo by cAMP/PKA-activated p85alphaPI3K.Expression of insulin-like growth factor system genes during the early postnatal neurogenesis in the mouse hippocampusInhibition of the proteolytic activity of pregnancy-associated plasma protein-A by targeting substrate exosite binding.Cardiac insulin-like growth factor-1 and cyclins gene expression in canine models of ischemic or overpacing cardiomyopathy.Biomarkers in acute myocardial infarction.Insulin-like growth factor-1 as a prognostic marker in patients with acute ischemic strokeMechanical stretch and intimal hyperplasia: the missing link?Inhibition of IGF-1 receptor kinase blocks the differentiation into cardiomyocyte-like cells of BMSCs induced by IGF-1Age-related changes in redox signaling and VSMC function.AMP-activated protein kinase inhibits IGF-I signaling and protein synthesis in vascular smooth muscle cells via stimulation of insulin receptor substrate 1 S794 and tuberous sclerosis 2 S1345 phosphorylation.Integrative proteomic analysis of the NMDA NR1 knockdown mouse model reveals effects on central and peripheral pathways associated with schizophrenia and autism spectrum disorders.Insulin-like growth factor-1 induces phosphorylation of PI3K-Akt/PKB to potentiate proliferation of smooth muscle cells in human saphenous veinNew developments in endovascular interventions for extracranial carotid stenosis.Transgenic overexpression of pregnancy-associated plasma protein-A in murine arterial smooth muscle accelerates atherosclerotic lesion developmentIGF-1 has plaque-stabilizing effects in atherosclerosis by altering vascular smooth muscle cell phenotype.Are elevated levels of IGF-1 caused by coronary arteriesoclerosis?: Molecular and clinical analysisCross-talk between angiotensin II and IGF-1-induced connexin 43 expression in human saphenous vein smooth muscle cells.Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting.Biology of infantile hemangiomaAging and gastrointestinal neuromuscular function: insights from within and outside the gut.Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cellsThe relationship between serum insulin-like growth factor I levels and ischemic stroke riskEstrogens and selective estrogen receptor modulators regulate gene and protein expression in the mesenteric arteriesAssociations between Fatness, Fitness, IGF and IMT among Obese Korean Male Adolescents.Exogenous estrogen as mediator of racial differences in bioactive insulin-like growth factor-I levels among postmenopausal womenFirst Trimester Aneuploidy Screening Markers in Women with Pre-Gestational Diabetes Mellitus.Hypertension in diabetes: the role of the vasculature.Involvement of chloride channels in IGF-I-induced proliferation of porcine arterial smooth muscle cells.Impact of Inherited Prothrombotic Disorders on the Long-Term Clinical Outcome of Percutaneous Transluminal Angioplasty in Patients with Diabetes.Aging, atherosclerosis, and IGF-1Changing paradigm for neointimal cell origin: is restenosis a blood-borne disease?Serum insulin-like growth factor binding protein 6 (IGFBP6) is increased in patients with type 1 diabetes and its complications.Circulating primers enhance platelet function and induce resistance to antiplatelet therapy.
P2860
Q24647879-9572F665-C68D-4A52-9FCA-47AB02D866B8Q24657968-2AE249F4-B5BD-4DE0-B39C-6F4AA48E1085Q24811176-F1E7B08D-4FBA-442E-8F5A-716454A5DB56Q24814578-7B14350E-5640-4583-8FE8-DD5A09D17FA5Q27694593-E6F50ED0-5C0D-4971-9850-5280643AFC73Q28579027-9E54F1BA-160E-4CE5-A293-0A6FC8B06410Q28582797-E4886ADB-A50C-415D-BC5D-40313A5F9DC7Q29347010-44AD1947-8042-41BD-91AD-74DC122E1200Q33282608-67A2C994-45EF-407F-8278-7567064D0228Q33330587-A8AB35D0-40D9-47E4-9F9D-9C513F77B01FQ33509646-90108590-3A43-4538-B67A-D79A63108695Q33596823-599C5798-D7BC-4997-A929-E19FD4216723Q33728636-475D2204-9199-4B7A-890E-809478F27C18Q33750575-12ED24EE-D5D8-4237-9214-CC3CC15F4E3CQ33828282-75FDFFFB-29DE-4F05-9200-EAC436ACD8D6Q33830145-88280DDD-1112-4512-804E-427FBABACD02Q33874358-8B9CD637-9DB8-4C1A-8013-9A0F785B0AB3Q33945211-FAA04A6F-AC65-4490-8F67-4D8717689ED7Q33976843-56D62C5E-4C32-4161-9778-18DC41926ED6Q34091045-AC60B53F-46F8-4216-BE3F-D51603F9D09EQ34092815-EB2D4D91-512B-4379-8D64-A4F7E4C47DA3Q34161681-E07969B5-8E9D-4F58-ACB0-30B1D5FBE0F6Q34354643-480EE2CC-CA6B-4B5F-8DF9-D68294FADC42Q34398211-B9019D73-0B34-4E5B-B81F-D0E4B5BDE900Q34793647-CF05A395-2A9E-4E9D-8F32-8800190BA1EBQ34867993-B07C22D0-CCDC-4C32-9BBC-B42022BF5580Q34981170-7B8DD8C4-F27D-485E-8AE3-9FB288CC460BQ35000871-0BE3D681-D564-41D5-AA94-761AAA884F07Q35146896-5401D170-220D-40D5-B2FB-A035F6AECF98Q35175559-303C147E-6291-45FD-B8D4-23CC9D504161Q35661444-5295B5B4-C418-4CF1-983F-2465FAEFBA03Q35661787-100FF4A0-4EF5-45B6-B12E-3ECF6009F042Q35667236-21265FA9-F92B-432C-999B-73D10326952CQ35686190-C15C41CA-6740-4880-9E13-9B8E008CCE63Q35752059-1A813283-C206-4B4D-93B5-9D328C3136A1Q35890411-65396B5F-F80A-40D9-8642-7CE6941FE5D2Q35947440-183049FE-CB20-4FCC-B12C-71946256A730Q36079425-8F2245A6-184E-427D-9BF2-E3C7667EEA81Q36111636-476A23BC-5B59-41A3-9DD3-1227872B2485Q36140286-5E327B5B-AC7A-43FB-817A-EFEBAFF4D173
P2860
The insulin-like growth factor axis: A review of atherosclerosis and restenosis.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The insulin-like growth factor axis: A review of atherosclerosis and restenosis.
@ast
The insulin-like growth factor axis: A review of atherosclerosis and restenosis.
@en
type
label
The insulin-like growth factor axis: A review of atherosclerosis and restenosis.
@ast
The insulin-like growth factor axis: A review of atherosclerosis and restenosis.
@en
prefLabel
The insulin-like growth factor axis: A review of atherosclerosis and restenosis.
@ast
The insulin-like growth factor axis: A review of atherosclerosis and restenosis.
@en
P2093
P356
P1433
P1476
The insulin-like growth factor axis: A review of atherosclerosis and restenosis.
@en
P2093
Bayes-Genis A
Conover CA
Schwartz RS
P304
P356
10.1161/01.RES.86.2.125
P577
2000-02-01T00:00:00Z